Loading...
XSHE
300396
Market cap255mUSD
Jul 10, Last price  
6.49CNY
1D
2.04%
1Q
-45.09%
Jan 2017
-69.12%
IPO
-37.58%
Name

Dirui Industrial Co Ltd

Chart & Performance

D1W1MN
XSHE:300396 chart
P/E
P/S
2.19
EPS
Div Yield, %
4.09%
Shrs. gr., 5y
-0.21%
Rev. gr., 5y
-2.28%
Revenues
807m
-33.73%
175,648,733231,187,389358,055,014413,634,969464,403,760486,472,263567,325,998758,694,232867,690,655867,690,654933,418,5971,008,790,834937,235,914905,795,040905,795,0391,220,007,7871,220,007,7871,378,059,4701,217,807,734807,057,922
Net income
0k
-100.00%
18,708,17860,389,01576,310,62484,222,59993,607,830101,358,867108,278,049125,136,156167,392,770167,392,775197,727,883231,892,241267,071,668209,948,414209,948,417261,827,947261,827,951275,589,643141,922,5560
CFO
39m
P
3,863,65213,600,78939,078,52065,416,15284,881,039124,170,678151,978,228213,738,344230,957,557236,304,453291,102,980235,647,142167,412,92740,924,699224,498,855-294,752,32038,799,820
Dividend
May 20, 20250.26 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Established in 1992, Dirui Industrial Co.,Ltd. focuses on the research, production, and marketing of diagnostic medical solutions, primarily within the People's Republic of China. The company's product portfolio encompasses a variety of medical apparatus, diagnostic reagents, and testing strips. They provide advanced analyzers for diverse applications, including biochemical blood cell analysis, urinalysis, coagulation studies, chemiluminescence immunoassay, and gynecological secretion examinations. Its corporate headquarters are located in Changchun, China.
IPO date
Sep 10, 2014
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122023‑002022‑122022‑002021‑122020‑122019‑122018‑122018‑002017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT